Company Search:
Advanced Search
Sponsored Links
Invion Limited Company Snapshot
Invion Limited operates in the Commercial physical research sector. In addition to historical fundamental analyses, the complete report available to purchase compares Invion Limited with three other companies in this sector in AUSTRALIA : Exopharm Ltd (2020 sales of 2.67 million Australian Dollars [US$2.07 million] ), Imugene Limited (4.21 million Australian Dollars [US$3.28 million] of which 100% was Health technologies), and Oncosil Medical Ltd (2.87 million Australian Dollars [US$2.23 million] of which 100% was Medical Treatments).

Sales Analysis. Invion Limited reported sales of A$3.48 million (US$2.71 million) for the fiscal year ending June of 2020. This represents a decrease of 10.4% versus 2019, when the company's sales were A$3.88 million.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Invion Limited
  Stock Performance Chart for Invion Limited
  Stock Data: Recent Stock Performance:
  Current Price (5/14/2021): .01
(Figures in Australian Dollars)
1 Week 0.0%   13 Weeks 11.1%  
4 Weeks -9.1%   52 Weeks 25.0%  
Invion Limited Key Data:
  Ticker: IVX Country: Australia
  Exchanges: FRA ASX Major Industry: Commercial Services & Supplies
    Sub Industry: Commercial Physical Research
  2020 Sales 3,476,784
(Year Ending Jan 2021).
Employees: 8
  Currency: Australian Dollars Market Cap: 55,377,923
  Fiscal Yr Ends: June Shares Outstanding: 5,537,792,295
  Share Type: Ordinary Closely Held Shares: 3,969,963,493
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.